COA Continues Effort to Stop Most Favored Nation Model
The Community Oncology Alliance's request includes declarations from community oncology practices detailing the anticipated ramifications should the Most Favored Nation rule become operative.
The Community Oncology Alliance (COA) filed a motion for preliminary injunction and restraining order in an effort to prevent CMS from implementing the Trump administration’s
The MFN interim final rule has been widely criticized by COA and other advocates for oncology practices, who agree that the rule meant to lower drug prices has the potential to cause irreparable harm to community oncologists and, in turn, cause Medicare patients to lose access to care. It would drastically reduce physician reimbursement for the 50 drugs it targets, 38 of which are used by oncologists to treat cancer and blood disorders.
“Here you have community oncology practices that are literally struggling every day to keep their facilities and their staff COVID-19 free, especially in the middle of what is a third wave—and an unchecked third wave—in this pandemic, to get a rule put on them that in a little over a month, will radically reduce the reimbursement for these drugs,” Okon told The American Journal of Managed Care® in an interview when the rule was first announced. “It’s going to put more pressure on these practices and it’s going to end up that some of these drugs are reimbursed at less than cost.”
COA’s request includes declarations from community oncology practices detailing the anticipated ramifications should the rule become operative. Oncologists would suffer business-threatening losses by either accepting below-cost reimbursement or having to transition seniors, a significant volume of their practices, to other providers such as hospitals.
“At its core, the MFN Interim Final Rule is a dangerous and unlawful gamble with the lives of some of America’s sickest and oldest cancer patients who require chemotherapy, immunotherapies, and other potentially life-saving drugs,” the COA memorandum
References
1. COA Files for Preliminary Injunction and Restraining Order to Stop Most Favored Nation (MFN) Implementation. News release. Community Oncology Alliance; December 21, 2020. Accessed December 21, 2020. https://communityoncology.org/coa-files-for-preliminary-injunction-and-restraining-order-to-stop-most-favored-nation-mfn-implementation/
2. Community Oncology Alliance v. U.S. Department of Health and Human Services, Alex M. Azar II, Centers for Medicare and Medicaid Services, and Seema Verma, Civil Action No. 20-3604.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Radiotherapy Raises Risk of Complications After Limb STS Surgery
September 16th 2025
- miRNA Profiling May Unlock SCLC Biomarkers
September 13th 2025
- Value-Based Care Veterans, Surprised by EOM Results, Ponder Next Move
September 11th 2025
- FDA Approves Selumetinib for Children With NF1 and Inoperable Tumors
September 10th 2025